BIO logo

BIO R&D Expenses

Latest reported$261.10M
BIO TTM R&D Expenses ($0.00 → $261.10M)
High-resolution chart · PNG

BIO r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bio-Rad Laboratories, Inc. Class A Common Stock R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
69,018,000
68,697,000
68,140,000
70,423,000
65,051,000
58,571,000
51,200,000
43,000,000
42,200,000
41,900,000
41,300,000
43,800,000
44,600,000
45,200,000
46,100,000
43,600,000
42,300,000
40,700,000
39,500,000
38,200,000
37,000,000
35,900,000
34,700,000
33,700,000
32,500,000
31,300,000
30,200,000
21,900,000
14,600,000
7,300,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.